Shape the future of consumer health.
An overview of the Orphan Drug program in Australia. This report helps understand access pathways in Australia and timelines for patient access to therapies for rare diseases. Our experts have analysed trends in registration and reimbursement of orphan drugs following reforms to the program in July 2017.
Shape the future of consumer health.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
Richer real world data insights can drive smarter decisions.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.